Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AXSM | AMGN | VRTX | BMY | GILD |
| Company | Axsome Thera | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 86.50 | 262.21 | 407.20 | 57.66 | 93.17 |
| High | 87.96 | 264.73 | 410.82 | 57.88 | 94.25 |
| Low | 84.94 | 261.76 | 406.02 | 57.51 | 92.98 |
| Last | 87.19 | 264.05 | 409.66 | 57.65 | 94.15 |
| Change | +0.18 | -0.44 | +1.48 | -0.11 | +0.20 |
| % Change | +0.21% | -0.17% | +0.36% | -0.19% | +0.21% |
| Volume | 215,763 | 609,420 | 551,093 | 1,691,439 | 1,143,947 |
| 20-Day Average Volume | 481,163 | 4,179,643 | 1,792,291 | 11,102,691 | 7,008,443 |
| Previous Close | 87.01 | 264.49 | 408.18 | 57.76 | 93.95 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 94.60 | 271.23 | 449.15 | 57.81 | 92.44 |
| 20-Day Raw Stochastic | 14.52% | 36.60% | 32.78% | 52.79% | 91.64% |
| 20-Day Relative Strength | 41.28% | 33.40% | 34.85% | 53.78% | 58.73% |
| Weighted Alpha | +9.14 | -14.64 | -7.27 | +20.35 | +26.53 |
| Today's Opinion | 40% Buy | 88% Sell | 72% Sell | 80% Buy | 100% Buy |
| Previous Opinion | 24% Buy | 88% Sell | 72% Sell | 80% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 72% Sell | 8% Sell | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.53% since 12/18/24 | +2.17% since 12/18/24 | -8.34% since 12/18/24 | +1.52% since 12/18/24 | +3.86% since 12/18/24 |
| Low | 84.93 on 12/26/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 56.08 on 12/20/24 | 90.27 on 12/19/24 |
| High | 93.12 on 12/20/24 | 269.61 on 12/20/24 | 410.81 on 12/26/24 | 57.88 on 12/26/24 | 94.25 on 12/26/24 |
| 1-Month | |||||
| %Chg | -9.85% since 11/26/24 | -5.57% since 11/26/24 | -12.18% since 11/26/24 | -1.76% since 11/26/24 | +3.11% since 11/26/24 |
| Low | 84.93 on 12/26/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 |
| High | 102.42 on 12/04/24 | 283.64 on 11/29/24 | 476.46 on 12/10/24 | 60.09 on 12/03/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | -2.42% since 09/26/24 | -17.14% since 09/26/24 | -11.44% since 09/26/24 | +15.13% since 09/26/24 | +13.43% since 09/26/24 |
| Low | 80.85 on 10/10/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 50.71 on 09/27/24 | 82.82 on 10/01/24 |
| High | 105.00 on 11/13/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +13.42% since 06/26/24 | -15.48% since 06/26/24 | -13.47% since 06/26/24 | +35.78% since 06/26/24 | +35.90% since 06/26/24 |
| Low | 72.21 on 08/05/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 |
| High | 105.00 on 11/13/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,216,679 | 142,172,096 | 105,118,176 | 117,147,504 | 117,086,688 |
| Shares Outstanding, K | 48,462 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 270,600,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -239,240,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 104,760,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -64,600,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.18 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.34 on 11/12/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 02/18/25 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.74 | 0.00 | 49.21 | 21.08 |